VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 29 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -86.3% | 68,156 | +16.5% | 0.00% | – |
| Q1 2022 | $73,000 | -86.0% | 58,491 | -64.7% | 0.00% | – |
| Q2 2021 | $521,000 | +1140.5% | 165,645 | +731.3% | 0.00% | – |
| Q1 2021 | $42,000 | +10.5% | 19,925 | -72.7% | 0.00% | – |
| Q2 2020 | $38,000 | +31.0% | 72,961 | +226.6% | 0.00% | – |
| Q1 2019 | $29,000 | – | 22,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
| VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
| COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
| EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
| HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
| NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
| Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |